Kristin Beale

Goodwin

Contact
View Bio
RSS

Latest Posts › Sandoz

Share:

Amgen Files BPCIA Complaint Against Sandoz Regarding Denosumab

On May 1, 2023, Amgen filed a BPCIA complaint in the District of New Jersey against Sandoz related to Sandoz’s denosumab biosimilar of Amgen’s PROLIA® and XGEVA®. This is Amgen’s first BPCIA case filed with respect to a...more

5/11/2023  /  Amgen , Biosimilars , BPCIA , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , Sandoz
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide